Ekopimo Ibia

465 total citations
16 papers, 269 citations indexed

About

Ekopimo Ibia is a scholar working on Economics and Econometrics, Statistics and Probability and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Ekopimo Ibia has authored 16 papers receiving a total of 269 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Economics and Econometrics, 8 papers in Statistics and Probability and 3 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Ekopimo Ibia's work include Health Systems, Economic Evaluations, Quality of Life (9 papers), Statistical Methods in Clinical Trials (7 papers) and Advanced Causal Inference Techniques (4 papers). Ekopimo Ibia is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (9 papers), Statistical Methods in Clinical Trials (7 papers) and Advanced Causal Inference Techniques (4 papers). Ekopimo Ibia collaborates with scholars based in United States, Switzerland and France. Ekopimo Ibia's co-authors include Richard H. Schwartz, Bernhard L. Wiedermann, Bruce Binkowitz, Andreas Pikis, Michael J. Sheridan, Joshua Chen, Yoko Tanaka, Shailendra Menjoge, Hui Quan and Gang Li and has published in prestigious journals such as PEDIATRICS, Southern Medical Journal and Clinical Trials.

In The Last Decade

Ekopimo Ibia

16 papers receiving 256 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ekopimo Ibia United States 9 86 84 62 57 33 16 269
Jeremy A Schafer United States 9 6 0.1× 50 0.6× 70 1.1× 14 0.2× 37 1.1× 12 304
Lionel Van Holle Belgium 11 53 0.6× 83 1.0× 42 0.7× 7 0.1× 39 1.2× 17 385
Georgy Genov Netherlands 9 30 0.3× 59 0.7× 144 2.3× 26 0.5× 61 1.8× 14 389
José J. Hernández‐Muñoz United States 10 13 0.2× 14 0.2× 33 0.5× 26 0.5× 20 0.6× 40 317
Johannes P. Mouton South Africa 13 18 0.2× 18 0.2× 52 0.8× 18 0.3× 88 2.7× 23 415
Suzie Seabroke United Kingdom 8 43 0.5× 67 0.8× 51 0.8× 7 0.1× 46 1.4× 12 418
Anders Helldén Sweden 11 9 0.1× 39 0.5× 31 0.5× 21 0.4× 47 1.4× 23 417
А. С. Колбин Russia 7 6 0.1× 26 0.3× 45 0.7× 29 0.5× 34 1.0× 143 320
Maria Baltogianni Greece 8 10 0.1× 18 0.2× 47 0.8× 91 1.6× 50 1.5× 34 230
John Foxworth United States 8 4 0.0× 156 1.9× 3 0.0× 29 0.5× 32 1.0× 18 345

Countries citing papers authored by Ekopimo Ibia

Since Specialization
Citations

This map shows the geographic impact of Ekopimo Ibia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ekopimo Ibia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ekopimo Ibia more than expected).

Fields of papers citing papers by Ekopimo Ibia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ekopimo Ibia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ekopimo Ibia. The network helps show where Ekopimo Ibia may publish in the future.

Co-authorship network of co-authors of Ekopimo Ibia

This figure shows the co-authorship network connecting the top 25 collaborators of Ekopimo Ibia. A scholar is included among the top collaborators of Ekopimo Ibia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ekopimo Ibia. Ekopimo Ibia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Tanaka, Yoko, et al.. (2015). Defining Regions in Multiregional Clinical Trials: An Analytical Approach to Considering Impact of Intrinsic and Extrinsic Factors. Therapeutic Innovation & Regulatory Science. 50(1). 91–100. 1 indexed citations
2.
Chen, Joshua, Hao Zheng, Hui Quan, et al.. (2013). Graphical assessment of consistency in treatment effect among countries in multi-regional clinical trials. Clinical Trials. 10(6). 842–851. 6 indexed citations
3.
Girman, Cynthia J., Ekopimo Ibia, Shailendra Menjoge, et al.. (2011). Impact of Different Regulatory Requirements for Trial Endpoints in Multiregional Clinical Trials. Drug Information Journal. 45(5). 587–594. 9 indexed citations
4.
Binkowitz, Bruce, et al.. (2011). Results of a Survey of PhRMA Member Companies on Practices Associated with Multiregional Clinical Trials. Drug Information Journal. 45(5). 609–617. 1 indexed citations
5.
Tanaka, Yoko, Carmen Mak, Ekopimo Ibia, et al.. (2011). Points to Consider in Defining Region for a Multiregional Clinical Trial: Defining Region Work Stream in PhRMA MRCT Key Issue Team. Drug Information Journal. 45(5). 575–585. 4 indexed citations
6.
Gallo, Paul, Joshua Chen, Hui Quan, et al.. (2011). Consistency of Treatment Effect across Regions in Multiregional Clinical Trials, Part 2: Monitoring, Reporting, and Interpretation. Drug Information Journal. 45(5). 603–608. 13 indexed citations
7.
Chen, Joshua, Hui Quan, Paul Gallo, et al.. (2011). Consistency of Treatment Effect across Regions in Multiregional Clinical Trials, Part 1: Design Considerations. Drug Information Journal. 45(5). 595–602. 17 indexed citations
8.
Binkowitz, Bruce & Ekopimo Ibia. (2011). Multiregional Clinical Trials: An Introduction from an Industry Perspective. Drug Information Journal. 45(5). 569–573. 5 indexed citations
9.
Ibia, Ekopimo & Bruce Binkowitz. (2011). Proceedings of the DIA Workshop on Multiregional Clinical Trials, October 26–27, 2010. Drug Information Journal. 45(3). 391–403. 4 indexed citations
10.
Chen, Joshua, Hui Quan, Bruce Binkowitz, et al.. (2010). Assessing consistent treatment effect in a multi‐regional clinical trial: a systematic review. Pharmaceutical Statistics. 9(3). 242–253. 37 indexed citations
11.
Ibia, Ekopimo, et al.. (2010). Ethical considerations in industry‐sponsored Multiregional clinical trials. Pharmaceutical Statistics. 9(3). 230–241. 8 indexed citations
12.
Ibia, Ekopimo, Michael J. Sheridan, & Richard H. Schwartz. (2005). Knowledge of the Principles of Judicious Antibiotic Use for Upper Respiratory Infections: A Survey of Senior Medical Students. Southern Medical Journal. 98(9). 888–894. 28 indexed citations
13.
Ibia, Ekopimo, et al.. (2003). Group A β-Hemolytic Streptococcal Osteomyelitis in Children. PEDIATRICS. 112(1). e22–e26. 39 indexed citations
14.
Ibia, Ekopimo, Richard H. Schwartz, & Bernhard L. Wiedermann. (2000). Antibiotic Rashes in Children. Archives of Dermatology. 136(7). 849–54. 83 indexed citations
15.
Ibia, Ekopimo, et al.. (1992). Acquired immunodeficiency syndrome: education exposure, knowledge and attitude of Nigerian adolescents in Calabar. Annals of Tropical Paediatrics. 12(4). 397–402. 11 indexed citations
16.
Ibia, Ekopimo, et al.. (1990). Measles in Nigerian children in Calabar during the era of expanded programme on immunization.. PubMed. 42(3). 226–32. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026